Pyrrobutamine
ID: ALA1697849
Cas Number: 91-82-7
PubChem CID: 5284614
Max Phase: Unknown
Molecular Formula: C20H22ClN
Molecular Weight: 311.86
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
ID: ALA1697849
Cas Number: 91-82-7
PubChem CID: 5284614
Max Phase: Unknown
Molecular Formula: C20H22ClN
Molecular Weight: 311.86
Molecule Type: Small molecule
Associated Items:
Synonyms from Alternative Forms(2): Pyrrobutamine diphosphate | Pyrrobutamine phosphate
Canonical SMILES: Clc1ccc(C/C(=C\CN2CCCC2)c2ccccc2)cc1
Standard InChI: InChI=1S/C20H22ClN/c21-20-10-8-17(9-11-20)16-19(18-6-2-1-3-7-18)12-15-22-13-4-5-14-22/h1-3,6-12H,4-5,13-16H2/b19-12+
Standard InChI Key: WDYYVNNRTDZKAZ-XDHOZWIPSA-N
Molfile:
RDKit 2D 22 24 0 0 0 0 0 0 0 0999 V2000 2.0367 4.4759 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0 2.0367 3.6509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7512 3.2384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7512 2.4134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0367 2.0009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0367 1.1759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7512 0.7634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4656 1.1759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4656 2.0009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1801 2.4134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.8946 2.0009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.8946 1.1759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1801 0.7634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7512 -0.0616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7982 -1.7840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3222 2.4134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3222 3.2384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0367 -0.4741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0367 -1.2991 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.4002 -1.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7028 -2.5915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5262 -2.5410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 2 0 3 4 1 0 4 5 2 0 5 6 1 0 6 7 1 0 7 8 1 0 8 9 2 0 9 10 1 0 10 11 2 0 11 12 1 0 12 13 2 0 8 13 1 0 7 14 2 0 5 16 1 0 16 17 2 0 2 17 1 0 14 18 1 0 18 19 1 0 19 20 1 0 19 15 1 0 22 15 1 0 20 21 1 0 21 22 1 0 M END
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: Yes | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 311.86 | Molecular Weight (Monoisotopic): 311.1441 | AlogP: 5.06 | #Rotatable Bonds: 5 |
Polar Surface Area: 3.24 | Molecular Species: BASE | HBA: 1 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 8.91 | CX LogP: 5.41 | CX LogD: 3.89 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.75 | Np Likeness Score: -0.78 |
1. Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF.. (2008) Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models., 18 (2): [PMID:20020916] [10.1080/15376510701857262] |
2. WHO Anatomical Therapeutic Chemical Classification, |
Source(2):